Vital Transformation, a consultancy focused on addressing the challenges of modern healthcare systems, recently reviewed country-level COVID-19 data to determine the impact of widespread testing on both the spread of COVID-19 and the economic impact of COVID-19. Their results showed that countries that pursued a strategy of aggressive testing were more successful at managing the spread of the disease and are likely to suffer less economic impact. Dr. Luca Pani, VeraSci VP of Regulatory Strategy and Market Access Innovation collaborated on the review.

Results are published on the Vital Transformation website.